2nd Quarter - Report

TIBER CREEK GROUP for GILEAD SCIENCES, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to intellectual property protections for COVID-19 vaccines and treatments.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
COREY MALMGREN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169). Issues related to HIV.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
BRYANT HALL —
JONATHON JONES —
COREY MALMGREN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation Reduction Act of 2022 (PL 117-169).

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
BRYANT HALL —
JONATHON JONES —
COREY MALMGREN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Natural Resources NAT

Issues relating to the importation of non-human primates.

LobbyistCovered position, as disclosed
JONATHON JONES —

Contacted: U.S. Fish & Wildlife Service (USFWS); SENATE

Budget/Appropriations BUD

Issues related to FY2024 appropriations.

LobbyistCovered position, as disclosed
MATTHEW LEFFINGWELL New Mbr Servs & Coalitions Dir., House Approps Cmte (2016-2017); CoS, Rep. Kay Granger (2012-2015); Dep CoS, Rep. Granger (2010-2012); Comms Dir, Rep. Granger (2009-2010); Press Sec, Rep. Jon Porter (2007-2009); Projects Dir, Rep. Mark Kirk (2006-2007)

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.